Skip to main navigation
logo

Stock Quote & Chart

Our enduring purpose: to fundamentally improve the lives of patients with serious diseases in ways never before possible.

Stock Quote & Chart

(Common Stock)
Exchange:
Data as of
Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low
Sign up for email alerts

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Print Page
RSS Feeds
E-Mail Alerts
Contact IR
Investor Relations
  • Home
  • Press Releases
  • Corporate Governance
    • Highlights
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Events & Presentations
  • Financial Information
    • Financial Overview
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor Contact
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Strategic Collaborations
    • Contact
  • Our Programs
    • Pipeline
    • Cabiralizumab
    • Bemarituzumab
    • FPA150
    • FPT155
    • TIM-3
    • Clinical Trials
    • Expanded Access
  • Our Science
    • Platform
    • Protein Library
    • Proprietary Screens
    • Publications
  • Join Our Team
    • Culture
    • Careers
  • Investors & Media
    • Press Releases
    • Corporate Governance
      • Highlights
      • Management
      • Board Of Directors
      • Committee Composition
      • Contact The Board
    • Events & Presentations
    • Financial Information
      • Financial Overview
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor Contact
  • News
  • Publications
  • Contact
  • LinkedIn
  • Twitter
  • Home
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Strategic Collaborations
    • Contact
  • Our Programs
    • Pipeline
    • Cabiralizumab
    • Bemarituzumab
    • FPA150
    • FPT155
    • TIM-3
    • Clinical Trials
    • Expanded Access
  • Our Science
    • Platform
    • Protein Library
    • Proprietary Screens
    • Publications
  • Join Our Team
    • Culture
    • Careers
  • Investors & Media
    • Press Releases
    • Corporate Governance
      • Highlights
      • Management
      • Board Of Directors
      • Committee Composition
      • Contact The Board
    • Events & Presentations
    • Financial Information
      • Financial Overview
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor Contact
    • News
    • Publications
    • Contact
    • Linkedin
    • Twitter
    • Legal Notice
    • Privacy Policy

logo

© 2020 Five Prime Therapeutics, Inc. All rights reserved
  • Legal Notice
  • Privacy Policy
Website Design: Hane Chow, Inc.